JP2018530557A5 - - Google Patents

Download PDF

Info

Publication number
JP2018530557A5
JP2018530557A5 JP2018517362A JP2018517362A JP2018530557A5 JP 2018530557 A5 JP2018530557 A5 JP 2018530557A5 JP 2018517362 A JP2018517362 A JP 2018517362A JP 2018517362 A JP2018517362 A JP 2018517362A JP 2018530557 A5 JP2018530557 A5 JP 2018530557A5
Authority
JP
Japan
Prior art keywords
pyrazolo
pyridine
carboxylic acid
phenyl
cyclobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018517362A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018530557A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/056028 external-priority patent/WO2017060873A1/en
Publication of JP2018530557A publication Critical patent/JP2018530557A/ja
Publication of JP2018530557A5 publication Critical patent/JP2018530557A5/ja
Pending legal-status Critical Current

Links

JP2018517362A 2015-10-09 2016-10-07 置換ピラゾロ[3,4−b]ピリジン−6−カルボン酸およびこの使用 Pending JP2018530557A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562239475P 2015-10-09 2015-10-09
US62/239,475 2015-10-09
PCT/IB2016/056028 WO2017060873A1 (en) 2015-10-09 2016-10-07 Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and their use

Publications (2)

Publication Number Publication Date
JP2018530557A JP2018530557A (ja) 2018-10-18
JP2018530557A5 true JP2018530557A5 (https=) 2019-11-14

Family

ID=57200057

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018517362A Pending JP2018530557A (ja) 2015-10-09 2016-10-07 置換ピラゾロ[3,4−b]ピリジン−6−カルボン酸およびこの使用

Country Status (10)

Country Link
US (1) US9796711B2 (https=)
EP (1) EP3359539A1 (https=)
JP (1) JP2018530557A (https=)
CN (1) CN108431002A (https=)
AU (1) AU2016333855A1 (https=)
BR (1) BR112018007145A2 (https=)
CA (1) CA3001094A1 (https=)
MX (1) MX2018004364A (https=)
TW (1) TW201735769A (https=)
WO (1) WO2017060873A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10138227B2 (en) 2016-06-03 2018-11-27 Abbvie S.Á.R.L. Heteroaryl substituted pyridines and methods of use
US9981910B2 (en) 2016-10-07 2018-05-29 Abbvie S.Á.R.L. Substituted pyrrolidines and methods of use
US10399940B2 (en) 2016-10-07 2019-09-03 Abbvie S.Á.R.L. Substituted pyrrolidines and methods of use
EP3558982A1 (en) 2016-12-20 2019-10-30 AbbVie S.À.R.L. Deuterated cftr modulators and methods of use
TW201831471A (zh) 2017-02-24 2018-09-01 盧森堡商艾伯維公司 囊腫纖化症跨膜傳導調節蛋白的調節劑及其使用方法
EP3686196B1 (en) * 2017-09-20 2024-06-12 Hangzhou Innogate Pharma Co., Ltd. Polycyclic compound acting as ido inhibitor and/or ido-hdac dual inhibitor
WO2019193062A1 (en) 2018-04-03 2019-10-10 Abbvie S.Á.R.L Substituted pyrrolidines and their use
WO2020048827A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds
WO2020048828A1 (en) 2018-09-03 2020-03-12 Bayer Pharma Aktiengesellschaft 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds
WO2020048826A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 5-substituted 1-oxa-3,9-diazaspiro[5.5]undecan-2-one compounds
WO2020178316A1 (en) * 2019-03-05 2020-09-10 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.P.A. 5- or 7-azaindazoles as beta-lactamase inhibitors
GB201905711D0 (en) 2019-04-24 2019-06-05 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases
US11345691B2 (en) 2019-06-03 2022-05-31 AbbVie Global Enterprises Ltd. Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
WO2021011327A1 (en) 2019-07-12 2021-01-21 Orphomed, Inc. Compound for treating cystic fibrosis
EP4274828A1 (en) 2021-01-06 2023-11-15 AbbVie Global Enterprises Ltd. Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
US20220213041A1 (en) 2021-01-06 2022-07-07 AbbVie Global Enterprises Ltd. Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
KR20240168948A (ko) * 2022-02-08 2024-12-02 이턴 바이오파마 (상하이) 코., 엘티디. 바이사이클릭 헤테로아릴 화합물들 및 이의 용도들

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861304B1 (fr) * 2003-10-23 2008-07-18 Univ Grenoble 1 Modulateurs des canaux cftr
CA2569402A1 (en) 2004-06-04 2005-12-22 The Regents Of The University Of California Compounds having activity in increasing ion transport by mutant-cftr and uses thereof
RS56037B1 (sr) 2004-06-24 2017-09-29 Vertex Pharma Modulatori atp-vezujućih kasetnih transportera
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US8362031B2 (en) * 2004-08-20 2013-01-29 University Of Kansas Lonidamine analogues and treatment of polycystic kidney disease
BRPI0708615A2 (pt) * 2006-03-07 2011-06-07 Array Biopharma Inc compostos de pirazol heterobicìclicos e métodos de uso
JP5686596B2 (ja) 2007-05-25 2015-03-18 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated 嚢胞性線維症膜貫通コンダクタンス制御因子の調節因子
MX2010006421A (es) 2007-12-10 2010-06-25 Novartis Ag Compuestos organicos.
JP5637859B2 (ja) 2007-12-13 2014-12-10 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated 嚢胞性線維症膜コンダクタンスレギュレーターのモジュレーター
CN102224141B (zh) 2008-10-23 2014-10-08 沃泰克斯药物股份有限公司 N-(4-(7-氮杂双环[2.2.1]庚-7-基)-2-(三氟甲基)苯基)-4-氧代-5-(三氟甲基)-1,4-二氢喹啉-3-甲酰胺的固体形式
EP2382197B1 (en) 2008-12-30 2016-10-05 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
KR101886459B1 (ko) 2010-10-08 2018-08-07 니발리스 테라퓨틱스, 인코포레이티드 S-나이트로소글루타티온 리덕타제 억제제로서의 신규한 치환된 퀴놀린 화합물
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
CN103946221B (zh) 2011-09-16 2016-08-03 诺华股份有限公司 用于治疗囊性纤维化的杂环化合物
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
US9056867B2 (en) * 2011-09-16 2015-06-16 Novartis Ag N-substituted heterocyclyl carboxamides
AU2012312520A1 (en) 2011-09-20 2014-05-08 The University Of North Carolina At Chapel Hill Regulation of sodium channels by PLUNC proteins
EP2922852A4 (en) * 2012-11-20 2016-05-25 Discoverybiomed Inc SMALL MOLECULAR CFTR CORRECTORS
WO2014180562A1 (en) 2013-05-07 2014-11-13 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
PT3030568T (pt) 2013-08-08 2018-12-24 Galapagos Nv Tieno[2,3-c]piranos como moduladores de cftr
WO2015138909A1 (en) 2014-03-13 2015-09-17 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing cftr activity
US9745292B2 (en) 2014-03-13 2017-08-29 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing CFTR activity
MA41051B1 (fr) 2014-10-06 2020-11-30 Vertex Pharma Modulateurs du régulateur de conductance transmembranaire de la mucoviscidose
MX2017005663A (es) 2014-10-31 2018-03-01 Abbvie Sarl Tetrahidropiranos sustituidos y metodo de uso.
DK3212189T3 (da) 2014-10-31 2020-10-26 Abbvie Overseas Sarl Substituerede chromaner og fremgangsmåde til anvendelse deraf

Similar Documents

Publication Publication Date Title
JP2018530557A5 (https=)
US10988478B1 (en) Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
HRP20210935T1 (hr) Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak
JP2018529743A5 (https=)
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
RU2018115722A (ru) N-СУЛЬФОНИЛИРОВАННЫЕ ПИРАЗОЛО[3,4-b]ПИРИДИН-6-КАРБОКСАМИДЫ И СПОСОБ ИХ ПРИМЕНЕНИЯ
JP2017505327A5 (https=)
RU2484091C2 (ru) Производные изоксазоло-пиридина
JP2013526536A5 (https=)
JP2015524798A5 (https=)
JP2018530557A (ja) 置換ピラゾロ[3,4−b]ピリジン−6−カルボン酸およびこの使用
AR119209A1 (es) DERIVADOS DE PIRROLO[1,2-c]IMIDAZOL COMO INHIBIDORES DE EGFR
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
JPWO2019210828A5 (https=)
RU2018105684A (ru) Замещенные трициклические соединения и способ применения
RU2020129785A (ru) Фармацевтические производные 6,5-гетеробициклического кольца
JP2015522002A5 (https=)
JP2015537010A5 (https=)
HRP20210285T1 (hr) Derivati ((piridin-2-il)-amino)pirido[3,4-d]pirimidina i ((piridazin-3-il)-amino)pirido[3,4-d]pirimidina kao inhibitori cdk4/6 za liječenje npr. reumatoidnog artritisa, arterioskleroze, plućne fibroze, cerebralnog infarkta ili raka
JP2018522929A5 (https=)
JPWO2022147246A5 (https=)
JP7478676B2 (ja) Gaba a alpha5 pamとしての新規イソオキサゾリルエーテル誘導体
JP2022508523A5 (https=)
JPWO2022216573A5 (https=)
JPWO2020072504A5 (https=)